Access

Correspondence


Nature Medicine 14, 1008 - 1009 (2008)
doi:10.1038/nm1008-1008

SNO-hemoglobin and hypoxic vasodilation

Jonathan S Stamler1,2, David J Singel3 & Claude A Piantadosi1

  1. Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    e-mail: staml001@mc.duke.edu
  2. Department of Biochemistry, Duke University Medical Center, Durham, North Carolina 27710, USA
  3. Department of Chemistry and Biochemistry, Montana State University, Bozeman, Montana 59717, USA.

In a recent Letter in Nature Medicine, Isbell et al.1 state that S-nitrosohemoglobin (SNO-Hb) is not essential for hypoxic vasodilation on the basis of observations in mice in which both the alpha- and beta-chains of hemoglobin had been replaced with the human versions, with or without mutation of the Cys93 residue of the beta-chain (betaCys93) to alanine. More specifically, the authors indicate that betaCys93 mutation "resulted in no deficits in systemic or pulmonary hemodynamics.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Hemoglobin as a chariot for NO bioactivity

Nature Medicine News and Views (01 Jul 2002)

NO, SNO and low O 2

Nature Medicine News and Views (01 Oct 2001)